Article
Polygenic risk score as clinical utility in psychiatry: a clinical viewpoint.
Journal of human genetics - 1 Jan 2021
Ikeda Masashi, Saito Takeo, Kanazawa Tetsufumi, Iwata Nakao
Abstract excerpt
Genome-wide association studies (GWASs) have detected many susceptible variants for common diseases, including psychiatric disorders. However, because of the small effect size of each variant, clinical utility that aims for risk prediction and/or diagnostic assistance based on the individual "variants" is difficult to use. Therefore, to improve the statistical power, polygenic risk score (PRS) has been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
